Skip to main content
. Author manuscript; available in PMC: 2012 Oct 18.
Published in final edited form as: Cancers (Basel). 2010 May 4;2(2):773–793. doi: 10.3390/cancers2020773

Figure 4.

Figure 4

Effect of injected 1.0 mg α-gal glycolipids on tumor growth. (A) Pre-treated tumor; (B) Tumor on day 5 post α-gal glycolipids injection; (C) Tumor on day 15 post injection. Note the gradual regression of the tumor. The black spot developing in the skin near the regressing tumor was caused by a subcutaneous administration of α-gal glycolipids into normal skin, inducing local inflammation that results in transient activation of normal melanocytes.